Atara Biotherapeutics (ATRA)

• Market cap: $107M
• 1 day: 1.99%
• 5 days: 6.6%
• 1 month: -4.68%
• 3 months: 17.56%
• 6 months: 98.4%
• Year to date: 4.94%
• 1 year: 21.21%
• 5 years: -97.45%
• 10 years: -98.5%
• Sector: Healthcare
• Industry: Biotechnology

About: Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Employees: 38